CoChat

Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib

Levêque, Dominique, Becker, Guillaume, Bilger, Karin, Natarajan-Amé, Shanti · 2020 · Clinical Pharmacokinetics

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Dasatinib is an oral, once-daily tyrosine kinase inhibitor used in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia. Dasatinib is rapidly absorbed, with the time for maximal serum concentration varying between 0.25 and 1.5 h. Oral absorption is not affected by food. The absolute bioavailability of dasatinib in humans is unknown due to the lack of an intravenous formulation preventing calculation of the reference exposure. Dasatinib is eliminated through cytochrome P450 (CYP) 3A4-mediated metabolism, with a terminal half-life of 3-4 h. Based on total radioactivity, only 20% of the oral dose (100 mg) is recovered unchanged in faeces (19%, including potential non-absorption) and urine (1%) after 168 h. Dasatinib pharmacokinetics are not influenced by age (children, and adults up to 86 years of age), race and renal insufficiency. Dasatinib absorption is decreased by pH-modifying agents (antacids, H 2-receptor blockers, proton pump inhibitors), and dasatinib is also subject to drug interactions with CYP3A4 inducers or inhibitors.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40262-020-00872-4

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Cited by

See all 99

Metadata

Authors
Levêque, D., Becker, G., Bilger, K., & Natarajan-Amé, S.
Affiliations
Hôpital d'Hautepierre (FR)
Corresponding author
Levêque, Dominique
Venue
Clinical Pharmacokinetics
Published
2020-02-29
Volume
59
Issue
7
Pages
849-856
ISSN
  • 0312-5963 (ISSN-L)
  • 1179-1926
OpenAlex
W3007045996
Cited by
90
References
41
Citations by year
2026: 14 · 2025: 14 · 2024: 20 · 2023: 16 · 2022: 11 · 2021: 14 · 2020: 1
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Clinical Pharmacokinetics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
dasatinib, tyrosine kinase inhibitors, chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, pharmacokinetics, pharmacodynamics, CYP3A4 metabolism, bioavailability, drug interactions, food effect, renal failure
MeSH terms
Dasatinib, Antineoplastic Agents, Biological Availability, Drug Interactions, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib. https://app.cochat.ai/papers/10.1007/s40262-020-00872-4
The paper
Levêque, D., Becker, G., Bilger, K., & Natarajan-Amé, S. (2020). Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-020-00872-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.